APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anti-infective Drugs for Animals

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Anti-infective Drugs for Animals Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

31 December 2025185 pages

Choose your research edition.

Industry ResearchAnti-infective Drugs for Animals Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-infective Drugs for Animals Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Anti-infective Drugs for Animals Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-infective Drugs for Animals Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-infective Drugs for Animals Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Anti-infective Drugs for Animals market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Anti-infective Drugs for Animals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Anti-infective Drugs for Animals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anti-infective Drugs for Animals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Anti-infective Drugs for Animals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Anti-infective Drugs for Animals include AG Supply, Vetoquinol SA, Bayer, Boehringer Ingelheim, Phibro Animal Health Corporation, Elanco, Merck, Ceva Santé Animale and Zoetis Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Anti-infective Drugs for Animals market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Anti-infective Drugs for Animals and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Anti-infective Drugs for Animals sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Anti-infective Drugs for Animals market size, projected growth trends, production technologies, key applications, and end-use industries.

Anti-infective Drugs for Animals Segment by Company

AG Supply

Vetoquinol SA

Bayer

Boehringer Ingelheim

Phibro Animal Health Corporation

Elanco

Merck

Ceva Santé Animale

Zoetis Inc.

Anti-infective Drugs for Animals Segment by Type

Antifungals

Antibacterial

Antivirals

Others

Anti-infective Drugs for Animals Segment by Application

Cattle

Cats

Dogs

Other Animals

Anti-infective Drugs for Animals Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-infective Drugs for Animals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-infective Drugs for Animals and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-infective Drugs for Animals.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Anti-infective Drugs for Animals market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Anti-infective Drugs for Animals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Anti-infective Drugs for Animals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Anti-infective Drugs for Animals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Anti-infective Drugs for Animals Industry Trends Table 2. Anti-infective Drugs for Animals Industry Drivers Table 3. Anti-infective Drugs for Animals Industry Opportunities and Challenges Table 4. Anti-infective Drugs for Animals Industry Restraints Table 5. Global Anti-infective Drugs for Animals Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Anti-infective Drugs for Animals Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Anti-infective Drugs for Animals Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Anti-infective Drugs for Animals Sales Market Share by Manufacturers Table 9. Global Anti-infective Drugs for Animals Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Anti-infective Drugs for Animals Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Anti-infective Drugs for Animals Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Anti-infective Drugs for Animals Manufacturers, Product Type & Application Table 13. Global Anti-infective Drugs for Animals Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Anti-infective Drugs for Animals by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Antifungals Table 17. Major Manufacturers of Antibacterial Table 18. Major Manufacturers of Antivirals Table 19. Major Manufacturers of Others Table 20. Global Anti-infective Drugs for Animals Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Anti-infective Drugs for Animals Sales by Type (2021-2026) & (K Units) Table 22. Global Anti-infective Drugs for Animals Sales by Type (2027-2032) & (K Units) Table 23. Global Anti-infective Drugs for Animals Sales Market Share by Type (2021-2026) Table 24. Global Anti-infective Drugs for Animals Sales Market Share by Type (2027-2032) Table 25. Global Anti-infective Drugs for Animals Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Anti-infective Drugs for Animals Revenue by Type (2021-2026) & (K Units) Table 27. Global Anti-infective Drugs for Animals Revenue by Type (2027-2032) & (K Units) Table 28. Global Anti-infective Drugs for Animals Revenue Market Share by Type (2021-2026) Table 29. Global Anti-infective Drugs for Animals Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Cattle Table 31. Major Manufacturers of Cats Table 32. Major Manufacturers of Dogs Table 33. Major Manufacturers of Other Animals Table 34. Global Anti-infective Drugs for Animals Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Anti-infective Drugs for Animals Sales by Application (2021-2026) & (K Units) Table 36. Global Anti-infective Drugs for Animals Sales by Application (2027-2032) & (K Units) Table 37. Global Anti-infective Drugs for Animals Sales Market Share by Application (2021-2026) Table 38. Global Anti-infective Drugs for Animals Sales Market Share by Application (2027-2032) Table 39. Global Anti-infective Drugs for Animals Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global Anti-infective Drugs for Animals Revenue by Application (2021-2026) & (K Units) Table 41. Global Anti-infective Drugs for Animals Revenue by Application (2027-2032) & (K Units) Table 42. Global Anti-infective Drugs for Animals Revenue Market Share by Application (2021-2026) Table 43. Global Anti-infective Drugs for Animals Revenue Market Share by Application (2027-2032) Table 44. Global Anti-infective Drugs for Animals Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Anti-infective Drugs for Animals Sales by Region (2021-2026) & (K Units) Table 46. Global Anti-infective Drugs for Animals Sales Market Share by Region (2021-2026) Table 47. Global Anti-infective Drugs for Animals Sales Forecasted by Region (2027-2032) & (K Units) Table 48. Global Anti-infective Drugs for Animals Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Anti-infective Drugs for Animals Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. North America Anti-infective Drugs for Animals Sales by Country (2021-2026) & (K Units) Table 51. North America Anti-infective Drugs for Animals Sales by Country (2027-2032) & (K Units) Table 52. Europe Anti-infective Drugs for Animals Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Europe Anti-infective Drugs for Animals Sales by Country (2021-2026) & (K Units) Table 54. Europe Anti-infective Drugs for Animals Sales by Country (2027-2032) & (K Units) Table 55. Asia Pacific Anti-infective Drugs for Animals Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Asia Pacific Anti-infective Drugs for Animals Sales by Country (2021-2026) & (K Units) Table 57. Asia Pacific Anti-infective Drugs for Animals Sales by Country (2027-2032) & (K Units) Table 58. South America, Middle East and Africa Anti-infective Drugs for Animals Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. South America, Middle East and Africa Anti-infective Drugs for Animals Sales by Country (2021-2026) & (K Units) Table 60. South America, Middle East and Africa Anti-infective Drugs for Animals Sales by Country (2027-2032) & (K Units) Table 61. Global Anti-infective Drugs for Animals Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Anti-infective Drugs for Animals Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Anti-infective Drugs for Animals Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Anti-infective Drugs for Animals Revenue Market Share by Region (2021-2026) Table 65. Global Anti-infective Drugs for Animals Revenue Market Share by Region (2027-2032) Table 66. AG Supply Company Information Table 67. AG Supply Business Overview Table 68. AG Supply Anti-infective Drugs for Animals Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. AG Supply Anti-infective Drugs for Animals Product Portfolio Table 70. AG Supply Recent Development Table 71. Vetoquinol SA Company Information Table 72. Vetoquinol SA Business Overview Table 73. Vetoquinol SA Anti-infective Drugs for Animals Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Vetoquinol SA Anti-infective Drugs for Animals Product Portfolio Table 75. Vetoquinol SA Recent Development Table 76. Bayer Company Information Table 77. Bayer Business Overview Table 78. Bayer Anti-infective Drugs for Animals Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Bayer Anti-infective Drugs for Animals Product Portfolio Table 80. Bayer Recent Development Table 81. Boehringer Ingelheim Company Information Table 82. Boehringer Ingelheim Business Overview Table 83. Boehringer Ingelheim Anti-infective Drugs for Animals Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Boehringer Ingelheim Anti-infective Drugs for Animals Product Portfolio Table 85. Boehringer Ingelheim Recent Development Table 86. Phibro Animal Health Corporation Company Information Table 87. Phibro Animal Health Corporation Business Overview Table 88. Phibro Animal Health Corporation Anti-infective Drugs for Animals Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Phibro Animal Health Corporation Anti-infective Drugs for Animals Product Portfolio Table 90. Phibro Animal Health Corporation Recent Development Table 91. Elanco Company Information Table 92. Elanco Business Overview Table 93. Elanco Anti-infective Drugs for Animals Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Elanco Anti-infective Drugs for Animals Product Portfolio Table 95. Elanco Recent Development Table 96. Merck Company Information Table 97. Merck Business Overview Table 98. Merck Anti-infective Drugs for Animals Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Merck Anti-infective Drugs for Animals Product Portfolio Table 100. Merck Recent Development Table 101. Ceva Santé Animale Company Information Table 102. Ceva Santé Animale Business Overview Table 103. Ceva Santé Animale Anti-infective Drugs for Animals Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Ceva Santé Animale Anti-infective Drugs for Animals Product Portfolio Table 105. Ceva Santé Animale Recent Development Table 106. Zoetis Inc. Company Information Table 107. Zoetis Inc. Business Overview Table 108. Zoetis Inc. Anti-infective Drugs for Animals Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Zoetis Inc. Anti-infective Drugs for Animals Product Portfolio Table 110. Zoetis Inc. Recent Development Table 111. Key Raw Materials Table 112. Raw Materials Key Suppliers Table 113. Anti-infective Drugs for Animals Distributors List Table 114. Anti-infective Drugs for Animals Customers List Table 115. Research Programs/Design for This Report Table 116. Authors List of This Report Table 117. Secondary Sources Table 118. Primary Sources List of Figures Figure 1. Anti-infective Drugs for Animals Product Image Figure 2. Global Anti-infective Drugs for Animals Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-infective Drugs for Animals Market Size (2021-2032) & (US$ Million) Figure 4. Global Anti-infective Drugs for Animals Sales (2021-2032) & (K Units) Figure 5. Global Anti-infective Drugs for Animals Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Anti-infective Drugs for Animals Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Antifungals Image Figure 9. Antibacterial Image Figure 10. Antivirals Image Figure 11. Others Image Figure 12. Global Anti-infective Drugs for Animals Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Anti-infective Drugs for Animals Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Anti-infective Drugs for Animals Sales Market Share by Type (2021-2032) Figure 15. Global Anti-infective Drugs for Animals Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Anti-infective Drugs for Animals Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Anti-infective Drugs for Animals Revenue Market Share by Type (2021-2032) Figure 18. Cattle Image Figure 19. Cats Image Figure 20. Dogs Image Figure 21. Other Animals Image Figure 22. Global Anti-infective Drugs for Animals Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Anti-infective Drugs for Animals Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Anti-infective Drugs for Animals Sales Market Share by Application (2021-2032) Figure 25. Global Anti-infective Drugs for Animals Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Anti-infective Drugs for Animals Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Anti-infective Drugs for Animals Revenue Market Share by Application (2021-2032) Figure 28. North America Anti-infective Drugs for Animals Sales and Growth Rate (2021-2032) & (K Units) Figure 29. North America Anti-infective Drugs for Animals Sales Market Share by Country (2021-2032) Figure 30. U.S. Anti-infective Drugs for Animals Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Canada Anti-infective Drugs for Animals Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Mexico Anti-infective Drugs for Animals Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Anti-infective Drugs for Animals Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Anti-infective Drugs for Animals Sales Market Share by Country (2021-2032) Figure 35. Germany Anti-infective Drugs for Animals Sales and Growth Rate (2021-2032) & (K Units) Figure 36. France Anti-infective Drugs for Animals Sales and Growth Rate (2021-2032) & (K Units) Figure 37. U.K. Anti-infective Drugs for Animals Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Italy Anti-infective Drugs for Animals Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Netherlands Anti-infective Drugs for Animals Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Anti-infective Drugs for Animals Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Anti-infective Drugs for Animals Sales Market Share by Country (2021-2032) Figure 42. China Anti-infective Drugs for Animals Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Japan Anti-infective Drugs for Animals Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South Korea Anti-infective Drugs for Animals Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Southeast Asia Anti-infective Drugs for Animals Sales and Growth Rate (2021-2032) & (K Units) Figure 46. India Anti-infective Drugs for Animals Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Australia Anti-infective Drugs for Animals Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Anti-infective Drugs for Animals Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Anti-infective Drugs for Animals Sales Market Share by Country (2021-2032) Figure 50. Brazil Anti-infective Drugs for Animals Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South Africa Anti-infective Drugs for Animals Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Saudi Arabia Anti-infective Drugs for Animals Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Turkey Anti-infective Drugs for Animals Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Argentina Anti-infective Drugs for Animals Sales and Growth Rate (2021-2032) & (K Units) Figure 55. UAE Anti-infective Drugs for Animals Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Egypt Anti-infective Drugs for Animals Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Chile Anti-infective Drugs for Animals Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Global Anti-infective Drugs for Animals Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Anti-infective Drugs for Animals Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Anti-infective Drugs for Animals Revenue (2021-2032) & (US$ Million) Figure 61. North America Anti-infective Drugs for Animals Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Anti-infective Drugs for Animals Revenue (2021-2032) & (US$ Million) Figure 63. Europe Anti-infective Drugs for Animals Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Anti-infective Drugs for Animals Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Anti-infective Drugs for Animals Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Anti-infective Drugs for Animals Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Anti-infective Drugs for Animals Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Anti-infective Drugs for Animals Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Anti-infective Drugs for Animals Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Antifungals
  • Antibacterial
  • Antivirals
  • Others
Applications
  • Cattle
  • Cats
  • Dogs
  • Other Animals
Companies covered
  • AG Supply
  • Vetoquinol SA
  • Bayer
  • Boehringer Ingelheim
  • Phibro Animal Health Corporation
  • Elanco
  • Merck
  • Ceva Santé Animale
  • Zoetis Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Anti-infective Drugs for Animals Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Anti-infective Drugs for Animals Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Anti-infective Drugs for Animals Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Anti-infective Drugs for Animals Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Anti-infective Drugs for Animals Market Dynamics
  1. 2.1 Anti-infective Drugs for Animals Industry Trends
  2. 2.2 Anti-infective Drugs for Animals Industry Drivers
  3. 2.3 Anti-infective Drugs for Animals Industry Opportunities and Challenges
  4. 2.4 Anti-infective Drugs for Animals Industry Restraints
3 Anti-infective Drugs for Animals Market by Manufacturers
  1. 3.1 Global Anti-infective Drugs for Animals Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Anti-infective Drugs for Animals Sales by Manufacturers (2021-2026)
  3. 3.3 Global Anti-infective Drugs for Animals Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Anti-infective Drugs for Animals Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Anti-infective Drugs for Animals Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Anti-infective Drugs for Animals Manufacturers, Product Type & Application
  7. 3.7 Global Anti-infective Drugs for Animals Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Anti-infective Drugs for Animals Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Anti-infective Drugs for Animals Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Anti-infective Drugs for Animals Tier 1, Tier 2, and Tier 3
4 Anti-infective Drugs for Animals Market by Type
  1. 4.1 Anti-infective Drugs for Animals Type Introduction
  2. 4.1.1 Antifungals
  3. 4.1.2 Antibacterial
  4. 4.1.3 Antivirals
  5. 4.1.4 Others
  6. 4.2 Global Anti-infective Drugs for Animals Sales by Type
  7. 4.2.1 Global Anti-infective Drugs for Animals Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Anti-infective Drugs for Animals Sales by Type (2021-2032)
  9. 4.2.3 Global Anti-infective Drugs for Animals Sales Market Share by Type (2021-2032)
  10. 4.3 Global Anti-infective Drugs for Animals Revenue by Type
  11. 4.3.1 Global Anti-infective Drugs for Animals Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Anti-infective Drugs for Animals Revenue by Type (2021-2032)
  13. 4.3.3 Global Anti-infective Drugs for Animals Revenue Market Share by Type (2021-2032)
5 Anti-infective Drugs for Animals Market by Application
  1. 5.1 Anti-infective Drugs for Animals Application Introduction
  2. 5.1.1 Cattle
  3. 5.1.2 Cats
  4. 5.1.3 Dogs
  5. 5.1.4 Other Animals
  6. 5.2 Global Anti-infective Drugs for Animals Sales by Application
  7. 5.2.1 Global Anti-infective Drugs for Animals Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Anti-infective Drugs for Animals Sales by Application (2021-2032)
  9. 5.2.3 Global Anti-infective Drugs for Animals Sales Market Share by Application (2021-2032)
  10. 5.3 Global Anti-infective Drugs for Animals Revenue by Application
  11. 5.3.1 Global Anti-infective Drugs for Animals Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Anti-infective Drugs for Animals Revenue by Application (2021-2032)
  13. 5.3.3 Global Anti-infective Drugs for Animals Revenue Market Share by Application (2021-2032)
6 Global Anti-infective Drugs for Animals Sales by Region
  1. 6.1 Global Anti-infective Drugs for Animals Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Anti-infective Drugs for Animals Sales by Region (2021-2032)
  3. 6.2.1 Global Anti-infective Drugs for Animals Sales by Region (2021-2026)
  4. 6.2.2 Global Anti-infective Drugs for Animals Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Anti-infective Drugs for Animals Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Anti-infective Drugs for Animals Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Anti-infective Drugs for Animals Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Anti-infective Drugs for Animals Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Anti-infective Drugs for Animals Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Anti-infective Drugs for Animals Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Anti-infective Drugs for Animals Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Anti-infective Drugs for Animals Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Anti-infective Drugs for Animals Revenue by Region
  1. 7.1 Global Anti-infective Drugs for Animals Revenue by Region
  2. 7.1.1 Global Anti-infective Drugs for Animals Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Anti-infective Drugs for Animals Revenue by Region (2021-2026)
  4. 7.1.3 Global Anti-infective Drugs for Animals Revenue by Region (2027-2032)
  5. 7.1.4 Global Anti-infective Drugs for Animals Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Anti-infective Drugs for Animals Revenue (2021-2032)
  8. 7.2.2 North America Anti-infective Drugs for Animals Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Anti-infective Drugs for Animals Revenue (2021-2032)
  11. 7.3.2 Europe Anti-infective Drugs for Animals Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Anti-infective Drugs for Animals Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Anti-infective Drugs for Animals Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Anti-infective Drugs for Animals Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Anti-infective Drugs for Animals Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 AG Supply
  2. 8.1.1 AG Supply Company Information
  3. 8.1.2 AG Supply Business Overview
  4. 8.1.3 AG Supply Anti-infective Drugs for Animals Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 AG Supply Anti-infective Drugs for Animals Product Portfolio
  6. 8.1.5 AG Supply Recent Developments
  7. 8.2 Vetoquinol SA
  8. 8.2.1 Vetoquinol SA Company Information
  9. 8.2.2 Vetoquinol SA Business Overview
  10. 8.2.3 Vetoquinol SA Anti-infective Drugs for Animals Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Vetoquinol SA Anti-infective Drugs for Animals Product Portfolio
  12. 8.2.5 Vetoquinol SA Recent Developments
  13. 8.3 Bayer
  14. 8.3.1 Bayer Company Information
  15. 8.3.2 Bayer Business Overview
  16. 8.3.3 Bayer Anti-infective Drugs for Animals Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Bayer Anti-infective Drugs for Animals Product Portfolio
  18. 8.3.5 Bayer Recent Developments
  19. 8.4 Boehringer Ingelheim
  20. 8.4.1 Boehringer Ingelheim Company Information
  21. 8.4.2 Boehringer Ingelheim Business Overview
  22. 8.4.3 Boehringer Ingelheim Anti-infective Drugs for Animals Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Boehringer Ingelheim Anti-infective Drugs for Animals Product Portfolio
  24. 8.4.5 Boehringer Ingelheim Recent Developments
  25. 8.5 Phibro Animal Health Corporation
  26. 8.5.1 Phibro Animal Health Corporation Company Information
  27. 8.5.2 Phibro Animal Health Corporation Business Overview
  28. 8.5.3 Phibro Animal Health Corporation Anti-infective Drugs for Animals Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Phibro Animal Health Corporation Anti-infective Drugs for Animals Product Portfolio
  30. 8.5.5 Phibro Animal Health Corporation Recent Developments
  31. 8.6 Elanco
  32. 8.6.1 Elanco Company Information
  33. 8.6.2 Elanco Business Overview
  34. 8.6.3 Elanco Anti-infective Drugs for Animals Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Elanco Anti-infective Drugs for Animals Product Portfolio
  36. 8.6.5 Elanco Recent Developments
  37. 8.7 Merck
  38. 8.7.1 Merck Company Information
  39. 8.7.2 Merck Business Overview
  40. 8.7.3 Merck Anti-infective Drugs for Animals Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Merck Anti-infective Drugs for Animals Product Portfolio
  42. 8.7.5 Merck Recent Developments
  43. 8.8 Ceva Santé Animale
  44. 8.8.1 Ceva Santé Animale Company Information
  45. 8.8.2 Ceva Santé Animale Business Overview
  46. 8.8.3 Ceva Santé Animale Anti-infective Drugs for Animals Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Ceva Santé Animale Anti-infective Drugs for Animals Product Portfolio
  48. 8.8.5 Ceva Santé Animale Recent Developments
  49. 8.9 Zoetis Inc.
  50. 8.9.1 Zoetis Inc. Company Information
  51. 8.9.2 Zoetis Inc. Business Overview
  52. 8.9.3 Zoetis Inc. Anti-infective Drugs for Animals Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Zoetis Inc. Anti-infective Drugs for Animals Product Portfolio
  54. 8.9.5 Zoetis Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Anti-infective Drugs for Animals Value Chain Analysis
  2. 9.1.1 Anti-infective Drugs for Animals Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Anti-infective Drugs for Animals Production Mode & Process
  6. 9.2 Anti-infective Drugs for Animals Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Anti-infective Drugs for Animals Distributors
  9. 9.2.3 Anti-infective Drugs for Animals Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst